Teva Pharmaceutical Industries Limited (TEVA) Earnings
|
Expand Research on TEVA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -0.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/27/22 | Q222 | N/A | $0.56 | N/A | N/A | $3.79B | N/A | N/A | N/A | ||
| 5/3/22 | Q122 | $0.55 | $0.55 | $0.00 | $3.7B | $3.74B | N/A | ![]() | ![]() | Details | |
| 2/9/22 | Q421 | $0.77 | $0.73 | +$0.04 | $4.1B | $4.29B | N/A | ![]() | ![]() | Details | |
| 10/27/21 | Q321 | $0.59 | $0.65 | -$0.06 | $3.9B | $4.03B | N/A | ![]() | ![]() | Details | |
| 7/28/21 | Q221 | $0.59 | $0.59 | $0.00 | $3.9B | $4.04B | N/A | ![]() | ![]() | Details | |
| 4/28/21 | Q121 | $0.63 | $0.59 | +$0.04 | $3.98B | $4.02B | N/A | ![]() | ![]() | Details | |
| 2/10/21 | Q420 | $0.68 | $0.63 | +$0.05 | $4.5B | $4.37B | N/A | ![]() | ![]() | Details | |
| 11/5/20 | Q320 | $0.58 | $0.58 | $0.00 | $4B | $4.07B | N/A | ![]() | ![]() | Details |

